Meta-Analysis: Vancomycin Treatment Failures for MRSA Bacteremia Based on MIC Determined by E-test

Background: Vancomycin is used to treat serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It is unclear whether MRSA isolates with minimum inhibitory concentration (MIC) 1.5 to 2 µg/mL are successfully treated with vancomycin. Objective: Evaluate vancomycin failure rat...

Full description

Saved in:
Bibliographic Details
Published in:The Journal of pharmacy technology 2016-04, Vol.32 (2), p.65-70
Main Authors: Kale-Pradhan, Pramodini B., Mariani, Nicholas P., Wilhelm, Sheila M., Johnson, Leonard B.
Format: Article
Language:English
Subjects:
Research Reports
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background: Vancomycin is used to treat serious infections caused by methicillin-resistant Staphylococcus aureus (MRSA). It is unclear whether MRSA isolates with minimum inhibitory concentration (MIC) 1.5 to 2 µg/mL are successfully treated with vancomycin. Objective: Evaluate vancomycin failure rates in MRSA bacteremia with an MIC
ISSN:8755-1225
1549-4810
DOI:10.1177/8755122515610125